World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
26023
World Ranking
13715
National Ranking
6965

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Arlene B. Chapman is affiliated with the University of Chicago in the United States. Their research primarily spans medicine and biochemistry, genetics, and molecular biology, with a particular focus on nephrology and genetics within those fields.

Their scientific work centers around several subfields including nephrology, genetics, pulmonary and respiratory medicine, molecular biology, and surgery. The main research topics cover genetic and kidney cyst diseases, pharmacogenetics and drug metabolism, dialysis and renal disease management, renal diseases and glomerulopathies, MRI in cancer diagnosis, cell adhesion molecules research, and studies related to blood pressure and hypertension.

Significant publication venues for Arlene B. Chapman include the Journal of the American Society of Nephrology, Kidney Medicine, Kidney360, Metabolites, and the American Journal of Nephrology.

Frequent coauthors collaborating with Chapman have included Rhonda M. Cooper-DeHoff, Bradley A. Warady, Peter Stenvinkel, Glenn M. Chertow, and John G. Gums.

Recent papers authored or coauthored by Chapman include:

  • A meta-analysis of GFR slope as a surrogate endpoint for kidney failure (2023, Nature Medicine)
  • Alport Syndrome Classification and Management (2020, Kidney Medicine)
  • Effects of Bardoxolone Methyl in Alport Syndrome (2022, Clinical Journal of the American Society of Nephrology)
  • KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary (2025, Kidney International)
  • Emerging Role of Clinical Genetics in CKD (2022, Kidney Medicine)

Chapman has been recognized as a member of the Association of American Physicians.

Best Publications

  • Tolvaptan in patients with autosomal dominant polycystic kidney disease

    Vicente E. Torres;Arlene B. Chapman;Olivier Devuyst;Olivier Devuyst;Ron T. Gansevoort

  • Volume Progression in Polycystic Kidney Disease

    Jared J. Grantham;Vicente E. Torres;Arlene B. Chapman;Lisa M. Guay-Woodford

  • Temporal relationships between hormonal and hemodynamic changes in early human pregnancy.

    Arlene B. Chapman;William T. Abraham;Stacy Zamudio;Carolyn Coffin

  • Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials

    María V. Irazabal;Laureano J. Rangel;Eric J. Bergstralh;Sara L. Osborn

  • Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

    Vicente E Torres;Arlene B Chapman;Olivier Devuyst;Olivier Devuyst;Ron T Gansevoort

  • Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Arlene B. Chapman;Olivier Devuyst;Kai-Uwe Eckardt;Ron T. Gansevoort

  • The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.

    Arlene B. Chapman;Ann Johnson;Patricia A. Gabow;Robert W. Schrier

  • Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

    Robert W. Schrier;Robert W. Schrier;Kaleab Z. Abebe;Ronald D. Perrone;Vicente E. Torres

  • Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

    Sandro Rossetti;Mark B. Consugar;Arlene B. Chapman;Vicente E. Torres

  • Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

    Arlene B. Chapman;Lisa M. Guay-Woodford;Jared J. Grantham;Vicente E. Torres

  • Intracranial aneurysms in autosomal dominant polycystic kidney disease.

    Arlene B. Chapman;David Rubinstein;Richard Hughes;John C. Stears

  • Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease

    Arlene B. Chapman;James E. Bost;Vicente E. Torres;Lisa Guay-Woodford

  • Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease

    Binu Porath;Vladimir G. Gainullin;Emilie Cornec-Le Gall;Emilie Cornec-Le Gall;Elizabeth K. Dillinger

  • Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

    Kyongtae T. Bae;Fang Zhu;Arlene B. Chapman;Vicente E. Torres

  • Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.

    Jared J. Grantham;Arlene B. Chapman;Vicente E. Torres

  • Cardiac and Renal Effects of Standard Versus Rigorous Blood Pressure Control in Autosomal-Dominant Polycystic Kidney Disease: Results of a Seven-Year Prospective Randomized Study

    Robert Schrier;Kimberly McFann;Ann Johnson;Arlene Chapman

  • Renal structure and hypertension in autosomal dominant polycystic kidney disease

    Patricia A. Gabow;Arlene B. Chapman;Ann M. Johnson;Douglas J. Tangel

  • Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease

    Vicente E. Torres;Kaleab Z. Abebe;Arlene B. Chapman;Robert W. Schrier

  • The primary glycosylation defect in class E Thy-1-negative mutant mouse lymphoma cells is an inability to synthesize dolichol-P-mannose.

    A. Chapman;K. Fujimoto;Stuart Kornfeld

  • Cyst Number but Not the Rate of Cystic Growth Is Associated with the Mutated Gene in Autosomal Dominant Polycystic Kidney Disease

    Peter C Harris;Kyongtae T Bae;Sandro Rossetti;Vicente E Torres

Frequent Co-Authors

Julie A. Johnson
Julie A. Johnson University of Florida
Eric Boerwinkle
Eric Boerwinkle The University of Texas Health Science Center at Houston
Kyongtae T. Bae
Kyongtae T. Bae University of Pittsburgh
Jared J. Grantham
Jared J. Grantham University of Kansas
Kent R. Bailey
Kent R. Bailey Mayo Clinic
Peter C. Harris
Peter C. Harris Mayo Clinic
Ron T. Gansevoort
Ron T. Gansevoort University Medical Center Groningen
Olivier Devuyst
Olivier Devuyst University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The healthcare field offers diverse career pathways beyond the traditional MD, many of which can be pursued through online education. For those interested in mental health, there are psychiatric np programs that prepare graduates to address the growing demand for mental health professionals. These advanced nursing programs combine clinical skills with psychiatric care, opening opportunities for certified psychiatric nurse practitioners.

If you are drawn to the administrative side of healthcare, online healthcare administration programs and masters in healthcare administration cost are crucial to consider. Online programs provide flexibility for working professionals and can lead to leadership roles in hospitals, clinics, and public health organizations. Exploring affordable options helps minimize debt while pursuing advanced education.

For nurses aiming for the highest level of clinical expertise, the cheapest dnp online programs offer a pathway to a Doctor of Nursing Practice — a degree that prepares nurses for evidence-based practice and leadership in healthcare systems.

Best Scientists Citing Arlene B. Chapman

Trending Scientists